Recent discussions on X about Amrize Ltd (AMRZ) have been sparked by the company's Q2 2025 earnings report and significant insider buying activity. Many users have noted the earnings release, which showed a performance below analyst expectations, leading to a pre-market drop in stock price. The focus remains on whether the company can rebound with its full-year outlook amidst ongoing cost controls and strategic acquisitions.
Adding fuel to the conversation, posts on X have highlighted a substantial purchase of shares by the company's CEO, raising eyebrows and prompting speculation about confidence in future growth. Some users are debating if this signals a potential turnaround for the stock following recent challenges. The mix of earnings disappointment and insider optimism has kept the dialogue dynamic and engaging.
Note: This discussion summary was generated from an AI condensation of post data.
Amrize Ltd Insider Trading Activity
Amrize Ltd insiders have traded $AMRZ stock on the open market 34 times in the past 6 months. Of those trades, 34 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $AMRZ stock by insiders over the last 6 months:
- JAN PHILIPP JENISCH (Chairman & CEO) has made 14 purchases buying 1,095,000 shares for an estimated $51,793,745 and 0 sales.
- IAN A JOHNSTON (Chief Financial Officer) has made 12 purchases buying 10,500 shares for an estimated $500,986 and 0 sales.
- MARIO GROSS (Chief Supply Chain Officer) has made 2 purchases buying 7,600 shares for an estimated $358,050 and 0 sales.
- DENISE R SINGLETON (Chief Legal Officer & Corp Sec) purchased 4,000 shares for an estimated $190,560
- ROALD BROUWER (Chief Technology Officer) has made 4 purchases buying 3,000 shares for an estimated $141,167 and 0 sales.
- SAMUEL JONAS POLETTI (Chief Strategy & M&A Officer) purchased 1,280 shares for an estimated $59,161
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Amrize Ltd Analyst Ratings
Wall Street analysts have issued reports on $AMRZ in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- RBC Capital issued a "Outperform" rating on 08/08/2025
- JP Morgan issued a "Overweight" rating on 07/15/2025
- Truist Securities issued a "Buy" rating on 06/24/2025
- Morgan Stanley issued a "Overweight" rating on 06/24/2025
To track analyst ratings and price targets for Amrize Ltd, check out Quiver Quantitative's $AMRZ forecast page.
Amrize Ltd Price Targets
Multiple analysts have issued price targets for $AMRZ recently. We have seen 8 analysts offer price targets for $AMRZ in the last 6 months, with a median target of $57.0.
Here are some recent targets:
- Anthony Codling from RBC Capital set a target price of $54.0 on 08/08/2025
- Adrian Huerta from JP Morgan set a target price of $57.0 on 07/15/2025
- Pujarini Ghosh from Bernstein set a target price of $62.0 on 07/10/2025
- Jerry Revich from Goldman Sachs set a target price of $57.0 on 07/01/2025
- Arnaud Lehmann from B of A Securities set a target price of $56.0 on 06/26/2025
- Keith Hughes from Truist Securities set a target price of $60.0 on 06/24/2025
- Cedar Ekblom from Morgan Stanley set a target price of $62.0 on 06/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
